You are here

Can-Fite BioPharma

Spotlight – What is next in Nash

EP Vantage

Fri, 03/3/23 - 10:02 am

clinical trials

Arrowhead Pharmaceuticals

Can-Fite BioPharma

Hepagene Therapeutics

Ligand Pharmaceuticals

Madrigal Pharmaceuticals

NGM Biopharmaceuticals

NorthSea Therapeutics

Sagimet Biosciences

Terns Pharmaceuticals

Viking Therapeutics

After a delay, Can-Fite digs into subpopulation data as liver cancer drug fails to hit primary endpoint

Fierce Biotech

Wed, 03/27/19 - 11:34 pm

Can-Fite BioPharma

clinical trials

Top 6 Biotech Movers From The Past Week

24/7 Wall St

Sat, 09/19/15 - 03:36 pm

Can-Fite BioPharma

Intra-Cellular Therapies

Raptor Pharmaceuticals

TRACON Pharmaceuticals

FDA Grants Fast Track Designation to Can-Fite's CF102 in the Treatment of Liver Cancer

Yahoo

Thu, 09/17/15 - 09:59 am

Can-Fite BioPharma

hepatocellular carcinoma

Can-Fite's Phase II Liver Cancer Trial Approved in Europe

Yahoo

Mon, 05/11/15 - 09:20 am

Can-Fite BioPharma

Pipeline Setback at Can-Fite BioPharma, Shares Down

Yahoo/Zacks.com

Tue, 12/31/13 - 11:31 am

Can-Fite BioPharma